GV 2017 GP, L.P.'s Net Worth

$228 Million

Estimate Recalculated Jul 2, 2024 06:31AM EST

Who is GV 2017 GP, L.P.?

GV 2017 GP, L.P. has an estimated net worth of $228 Million. This is based on reported shares across multiple companies, which include Arcus Biosciences, Inc., Verve Therapeutics, Inc., Decibel Therapeutics, Inc., and Gitlab Inc..

SEC CIK

GV 2017 GP, L.P.'s CIK is 0001733339

Past Insider Trading and Trends

2021 was GV 2017 GP, L.P.'s most active year for acquiring shares with 3 total transactions. GV 2017 GP, L.P.'s most active month to acquire stocks was the month of January. 2022 was GV 2017 GP, L.P.'s most active year for disposing of shares, totalling 37 transactions. GV 2017 GP, L.P.'s most active month to dispose stocks was the month of October. 2021 saw GV 2017 GP, L.P. paying a total of $0.00 for 15,704,330 shares, this is the most they've acquired in one year. In 2022 GV 2017 GP, L.P. cashed out on 637,388 shares for a total of $14,837,299.65, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Arcus Biosciences, Inc. (RCUS) Snapshot price: $15.4

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1.92M
—
—
1.92M
Mar 19
Form 3
—
0
—
—
0
No matching records found

Gitlab Inc. (GTLB) Snapshot price: $72.835

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Oct 18
Form 3
—
0
—
—
0
No matching records found

Verve Therapeutics, Inc. (VERV) Snapshot price: $10.99

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-1.39%
-145.75K
$31.14
-$3,025,610.98
10.37M
Scheduled
Nov 4
Form 4
-2.19%
-234.66K
$34.23
-$5,310,657.90
10.47M
Scheduled
Nov 2 - Nov 3
Form 4
-2.36%
-256.98K
$37.79
-$6,501,030.76
10.62M
Scheduled
Oct 31 - Nov 1
Form 4
∞
6.32M
—
—
6.32M
Jun 21
Form 3
—
0
—
—
0
No matching records found

Decibel Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
494.65K
—
—
494.65K
Feb 17
Form 3
—
0
—
—
0
No matching records found